CALML5 and cancer: Moreover, the ‘HPV‐related CA cluster’ specifically expressed CALML5, which is closely associated with recurrence and survival outcomes in patients with HPV‐related cancers such as head‐and‐neck carcinoma and oropharyngeal cancer.